US Protectionism: Tariffs on EU & Mexico
This carefully selected group of stocks features American companies that could benefit from the upcoming 30% tariff on EU and Mexican imports. Our analysts have identified domestic manufacturers and suppliers that may gain competitive advantages as foreign goods become more expensive.
Your Basket's Financial Footprint
Summary of total market capitalisation and investor takeaways for the provided basket.
- Large-cap dominance generally implies lower risk, reduced volatility, and closer tracking of broad market performance.
- Generally best treated as a core, long-term holding rather than a speculative growth position.
- Likely to deliver steady, long-term value rather than explosive short-term gains.
GM: $62.15B
F: $49.99B
AXL: $715.54M
- Other
About This Group of Stocks
Our Expert Thinking
These tariffs create a potential competitive edge for US-based manufacturers. As imported goods become more expensive, domestic producers may see increased demand, stronger pricing power, and improved profitability, particularly in automotive and industrial sectors.
What You Need to Know
This group represents a tactical investment opportunity based on the announced 30% tariff increase taking effect August 2025. These companies compete directly with European and Mexican imports and may benefit from shifting market dynamics.
Why These Stocks
Our analysts selected US-based manufacturers and suppliers with revenues closely tied to domestic industrial activity. These companies produce vehicles, auto parts, machinery, and components that directly compete with soon-to-be-tariffed imports.
Why You'll Want to Watch These Stocks
Made in America Momentum
With a 30% tariff on foreign competitors coming in 2025, these US manufacturers could see a significant boost in market share and pricing power as imports become more expensive.
Industry Disruption Opportunity
This policy shift could reshape competition in automotive and manufacturing sectors, potentially creating winners among domestic producers as supply chains adjust to new economic realities.
Domestic Manufacturing Revival
These companies are at the forefront of a possible resurgence in US industrial activity, as tariffs incentivize more domestic production and potentially boost their sales and margins.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Drug Pricing Power | Major Pharma Stocks 2025
Following plans by major drugmakers to raise prices on hundreds of medications, the pharmaceutical industry is showcasing its significant pricing power. This development highlights an investment opportunity centered on established pharmaceutical companies capable of translating market dominance into revenue growth.
Automation & Software Investment Theme Overview
Recent labor data reveals a split market, with low private-sector jobless claims contrasting with high unemployment driven by federal layoffs. This dynamic creates an investment opportunity in companies providing automation, software, and efficiency-boosting services as businesses prioritize productivity over expanding their payrolls.
Oyo's IPO Plans: Hospitality Sector Recovery Explained
Global hospitality firm Oyo's parent company has revived its IPO plans, signaling renewed confidence in the travel market. This high-profile listing could ignite investor interest across the entire hospitality and travel technology sector, creating opportunities for related service providers.